BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 32383006)

  • 21. Sclerosing Polycystic Adenoma of Salivary Glands: A Novel Neoplasm Characterized by PI3K-AKT Pathway Alterations-New Insights Into a Challenging Entity.
    Skálová A; Baněčková M; Laco J; Di Palma S; Agaimy A; Ptáková N; Costes-Martineau V; Petersson BF; van den Hout MFCM; de Rezende G; Klubíčková N; Koblížek M; Koshyk O; Vaneček T; Leivo I
    Am J Surg Pathol; 2022 Feb; 46(2):268-280. PubMed ID: 34510113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-grade intraductal carcinoma of salivary gland: report of 3 cases with marked apocrine differentiation.
    Weinreb I; Tabanda-Lichauco R; Van der Kwast T; Perez-Ordoñez B
    Am J Surg Pathol; 2006 Aug; 30(8):1014-21. PubMed ID: 16861974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salivary Duct Carcinoma: An Update on Morphologic Mimics and Diagnostic Use of Androgen Receptor Immunohistochemistry.
    Udager AM; Chiosea SI
    Head Neck Pathol; 2017 Sep; 11(3):288-294. PubMed ID: 28321773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.
    Katabi N; Ghossein R; Ho A; Dogan S; Zhang L; Sung YS; Antonescu CR
    Hum Pathol; 2015 Jan; 46(1):26-33. PubMed ID: 25439740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression.
    Williams L; Thompson LD; Seethala RR; Weinreb I; Assaad AM; Tuluc M; Ud Din N; Purgina B; Lai C; Griffith CC; Chiosea SI
    Am J Surg Pathol; 2015 May; 39(5):705-13. PubMed ID: 25871467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-grade salivary duct carcinoma or low-grade intraductal carcinoma? Review of the literature.
    Kuo YJ; Weinreb I; Perez-Ordonez B
    Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S59-67. PubMed ID: 23821212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma.
    Hsieh MS; Lee YH; Chang YL
    Hum Pathol; 2016 Oct; 56():134-42. PubMed ID: 27327192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes.
    Di Palma S; Simpson RH; Marchiò C; Skálová A; Ungari M; Sandison A; Whitaker S; Parry S; Reis-Filho JS
    Histopathology; 2012 Oct; 61(4):629-43. PubMed ID: 22882517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Diagnostic Utility of RAS Q61R Mutation-specific Immunohistochemistry in Epithelial-Myoepithelial Carcinoma.
    Nakaguro M; Tanigawa M; Hirai H; Yamamoto Y; Urano M; Takahashi RH; Sukeda A; Okumura Y; Honda S; Tasaki K; Shimizu A; Tsukahara K; Tada Y; Matsubayashi J; Faquin WC; Sadow PM; Nagao T
    Am J Surg Pathol; 2021 Jul; 45(7):885-894. PubMed ID: 33481388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The implications of TrkA and MET aberrations in de novo salivary duct carcinoma.
    Ryu HJ; Koh YW; Yoon SO
    Hum Pathol; 2018 Nov; 81():18-25. PubMed ID: 29753009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-Grade Intraductal Carcinoma of the Parotid Gland: A Case Report and Literature Review.
    Russo D; Di Crescenzo RM; Varricchio S; Broggi G; Bizzoca ME; Troise S; Salzano G; Ilardi G; Merolla F
    Head Neck Pathol; 2021 Dec; 15(4):1359-1371. PubMed ID: 33501556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted molecular profiling of salivary duct carcinoma with rhabdoid features highlights parallels to other apocrine and discohesive neoplasms: which phenotype should drive classification?
    Rooper LM; Gagan J; Bishop JA
    Head Neck Pathol; 2022 Dec; 16(4):1063-1072. PubMed ID: 35794510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic Significance of HRAS Mutations in Epithelial-Myoepithelial Carcinomas Exhibiting a Broad Histopathologic Spectrum.
    Urano M; Nakaguro M; Yamamoto Y; Hirai H; Tanigawa M; Saigusa N; Shimizu A; Tsukahara K; Tada Y; Sakurai K; Isomura M; Okumura Y; Yamaguchi H; Matsubayashi J; Nagao T
    Am J Surg Pathol; 2019 Jul; 43(7):984-994. PubMed ID: 30994537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation.
    Hsieh MS; Wang H; Lee YH; Ko JY; Chang YL
    Hum Pathol; 2017 Mar; 61():9-18. PubMed ID: 27769871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraductal Carcinomas of the Salivary Gland.
    Todorovic E; Weinreb I
    Surg Pathol Clin; 2021 Mar; 14(1):1-15. PubMed ID: 33526215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Pancreatic Mucoepidermoid Carcinoma" Is not a Pancreatic Counterpart of CRTC1/3-MAML2 Fusion Gene-related Mucoepidermoid Carcinoma of the Salivary Gland, and May More Appropriately be Termed Pancreatic Adenosquamous Carcinoma With Mucoepidermoid Carcinoma-like Features.
    Saeki K; Ohishi Y; Matsuda R; Mochidome N; Miyasaka Y; Yamamoto H; Koga Y; Maehara Y; Nakamura M; Oda Y
    Am J Surg Pathol; 2018 Nov; 42(11):1419-1428. PubMed ID: 30138216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment.
    Nakaguro M; Tada Y; Faquin WC; Sadow PM; Wirth LJ; Nagao T
    Cancer Cytopathol; 2020 Oct; 128(10):693-703. PubMed ID: 32421944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment.
    Nardi V; Sadow PM; Juric D; Zhao D; Cosper AK; Bergethon K; Scialabba VL; Batten JM; Borger DR; Iafrate AJ; Heist RS; Lawrence DP; Flaherty KT; Bendell JC; Deschler D; Li Y; Wirth LJ; Dias-Santagata D
    Clin Cancer Res; 2013 Jan; 19(2):480-90. PubMed ID: 23186780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salivary duct carcinoma with rhabdoid features: a salivary counterpart of pleomorphic lobular carcinoma of the breast.
    Kusafuka K; Kawasaki T; Maeda M; Yamanegi K; Baba S; Ito Y; Inagaki H; Nakajima T
    Histopathology; 2017 Jan; 70(2):164-173. PubMed ID: 27079821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased ERBB2 Gene Copy Numbers Reveal a Subset of Salivary Duct Carcinomas with High Densities of Tumor Infiltrating Lymphocytes and PD-L1 Expression.
    Chatzopoulos K; Collins AR; Sotiriou S; Keeney MG; Visscher DW; Rivera M; Schembri-Wismayer DJ; Lewis JE; Greipp PT; Sukov WR; Chintakuntlawar AV; Price KA; Garcia JJ
    Head Neck Pathol; 2020 Dec; 14(4):951-965. PubMed ID: 32350809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.